Effect of Adding Magnesium Sulphate to Epidural Bupivacaine and Morphine on Post‐Thoracotomy Pain Management: A Randomized, Double‐Blind, Clinical Trial. (9th July 2018)
- Record Type:
- Journal Article
- Title:
- Effect of Adding Magnesium Sulphate to Epidural Bupivacaine and Morphine on Post‐Thoracotomy Pain Management: A Randomized, Double‐Blind, Clinical Trial. (9th July 2018)
- Main Title:
- Effect of Adding Magnesium Sulphate to Epidural Bupivacaine and Morphine on Post‐Thoracotomy Pain Management: A Randomized, Double‐Blind, Clinical Trial
- Authors:
- Farzanegan, Behrooz
Zangi, Mahdi
Saeedi, Kimia
Khalili, Ali
Rajabi, Mehdi
Jahangirifard, Alireza
Emami, Habib
Mahboobipour, Amir Ali
Baniasadi, Shadi - Abstract:
- Abstract: Post‐thoracotomy pain is very severe and may cause pulmonary complications. Thoracic epidural analgesia can greatly decrease the pain experience and its consequences. However, finding new methods to decrease the amount of administered opioids is an important issue of research. We aimed to evaluate the effect of adding epidural magnesium sulphate to bupivacaine and morphine on pain control and the amount of opioid consumption after thoracotomy. Eighty patients undergoing thoracotomy at a tertiary cardiothoracic referral centre were enrolled in a randomized, double‐blind trial. Patients were randomly allocated to two groups. Bupivacaine (12.5 mg) and morphine (2 mg) were administered epidurally to all patients at the end of operation. Patients in the magnesium (Mg) group received epidural magnesium sulphate (50 mg), and patients in the control (C) group received normal saline as an adjuvant. Visual analogue scale (VAS) score and the amount of morphine consumption were measured during 24 hr post‐operation. Thirty‐nine patients in the Mg group and 41 patients in the C group completed the study. Patients in the Mg group had significantly less VAS score at recovery time ( p < 0.05), 2 hr ( p < 0.01) and 4 hr ( p < 0.05) after surgery. The patient‐controlled analgesia pump was started earlier in the C group than in the Mg group ( p < 0.05). The amount of morphine needed in the Mg group was significantly lower than in the C group (5.64 ± 1.69 mg/24 hr versus 8.44 ± 3.98Abstract: Post‐thoracotomy pain is very severe and may cause pulmonary complications. Thoracic epidural analgesia can greatly decrease the pain experience and its consequences. However, finding new methods to decrease the amount of administered opioids is an important issue of research. We aimed to evaluate the effect of adding epidural magnesium sulphate to bupivacaine and morphine on pain control and the amount of opioid consumption after thoracotomy. Eighty patients undergoing thoracotomy at a tertiary cardiothoracic referral centre were enrolled in a randomized, double‐blind trial. Patients were randomly allocated to two groups. Bupivacaine (12.5 mg) and morphine (2 mg) were administered epidurally to all patients at the end of operation. Patients in the magnesium (Mg) group received epidural magnesium sulphate (50 mg), and patients in the control (C) group received normal saline as an adjuvant. Visual analogue scale (VAS) score and the amount of morphine consumption were measured during 24 hr post‐operation. Thirty‐nine patients in the Mg group and 41 patients in the C group completed the study. Patients in the Mg group had significantly less VAS score at recovery time ( p < 0.05), 2 hr ( p < 0.01) and 4 hr ( p < 0.05) after surgery. The patient‐controlled analgesia pump was started earlier in the C group than in the Mg group ( p < 0.05). The amount of morphine needed in the Mg group was significantly lower than in the C group (5.64 ± 1.69 mg/24 hr versus 8.44 ± 3.98 mg/24 hr; p < 0.001). Pruritus was seen in the C group (9.7%) and absent in the Mg group ( p < 0.05). Co‐administration of magnesium sulphate with bupivacaine and morphine for thoracic epidural analgesia after thoracotomy leads to a reduction in post‐operative pain score and the need for opioid administration. … (more)
- Is Part Of:
- Basic & clinical pharmacology & toxicology. Volume 123(2018)Supplement 5
- Journal:
- Basic & clinical pharmacology & toxicology
- Issue:
- Volume 123(2018)Supplement 5
- Issue Display:
- Volume 123, Issue 5 (2018)
- Year:
- 2018
- Volume:
- 123
- Issue:
- 5
- Issue Sort Value:
- 2018-0123-0005-0000
- Page Start:
- 602
- Page End:
- 606
- Publication Date:
- 2018-07-09
- Subjects:
- Pharmacology -- Periodicals
Toxicology -- Periodicals
Pharmacology -- Periodicals
Toxicology -- Periodicals
Pharmacology, Clinical -- Periodicals
Computer network resources
Electronic journals
615.1 - Journal URLs:
- http://firstsearch.oclc.org/journal=1742-7835;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1742-7843 ↗
http://www.blackwell-synergy.com/servlet/useragent?func=showIssues&code=pto ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/bcpt.13047 ↗
- Languages:
- English
- ISSNs:
- 1742-7835
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 1863.914250
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 8040.xml